This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Mirna C. Samano: Innovator in Nucleoside Analogues
Introduction
Mirna C. Samano is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of chemistry, particularly in the synthesis of nucleoside analogues. With a total of 2 patents to her name, her work has implications for antiviral drug development.
Latest Patents
One of her latest patents is focused on the process for the synthesis of nucleoside analogues, specifically 4-ethoxy-pyrimidines. These compounds are described as useful intermediates in preparing antiviral 1,3-oxathiolane nucleosides. This innovative approach highlights her expertise in medicinal chemistry and her commitment to advancing healthcare solutions.
Career Highlights
Mirna is currently employed at Glaxo Wellcome Inc., where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in developing new therapeutic options for viral infections, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Mirna has collaborated with notable colleagues, including Vicente Samano and Michael David Goodyear. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Mirna C. Samano is a trailblazer in the field of nucleoside analogues, with a focus on antiviral applications. Her contributions to science and medicine are invaluable, and her ongoing work promises to yield further advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile